Download PDF
CC BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2018; 22(03): 245-249
DOI: 10.1055/s-0037-1605376
Original Research
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Sudden Sensorineural Hearing Loss: Comparative Study of Different Treatment Modalities

Ahmed Khater
1   Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Zagazig University, Zagazig, Egypt
,
Mohammad Waheed El-Anwar
1   Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Zagazig University, Zagazig, Egypt
,
Ahmad Abdel-Fattah Nofal
1   Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Zagazig University, Zagazig, Egypt
,
Atef Taha Elbahrawy
1   Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Zagazig University, Zagazig, Egypt
› Author Affiliations
Further Information

Publication History

24 September 2016

03 July 2017

Publication Date:
12 September 2017 (online)

   Permissions and Reprints

Abstract

Introduction Idiopathic sudden sensorineural hearing loss (ISSNHL) is hearing loss of at least 30 dB in at least 3 contiguous frequencies within at least 72 hours. There are many different theories to explain it, and many different modalities are used for its management, such as: systemic steroids (SSs), intratympanic steroid injection (ITSI), hyperbaric oxygen therapy (HOT), antiviral drugs, and vasodilators or vasoactive substances.

Objectives This study aims to evaluate the efficacy of the combination of the most common treatment modalities of ISSNHL and to compare the results if HOT was not one of the treatment modalities administered.

Methods The study was conducted with 22 ISSNHL patients with ages ranging from 34 to 58 years. The patients were divided into 2 groups; group A included 11 patients managed by SSs, ITSI, antiviral therapy, and HOT simultaneously, and group B included 11 patients exposed to the aforementioned modalities, with the exception of HOT.

Results After one month, all of the patients in group A showed total improvement in hearing in all frequencies, with pure tone average (PTA) of 18.1 ± 2.2, while in group B, 5/11 (45.5%) patients showed total improvement, and 6 /11 (54.5%) patients showed partial improvement, with a total mean PTA of 28.1 ± 8.7.

Conclusion The early administration of HOT in combination with other clinically approved modalities (SSs, ITSI, antiviral therapy) provides better results than the administration of the same modalities, with the exception of HOT, in the treatment of ISSNHL.

Keywords

hearing loss - hyperbaric oxygen therapy - steroids - intratympanic injection
 

  • References

  • 1 O'Malley MR, Haynes DS. Sudden hearing loss. Otolaryngol Clin North Am 2008; 41 (03) 633-649 , x–xi
    CrossrefPubMedGoogle Scholar
  • 2 Byl Jr FM. Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope 1984; 94 (5 Pt 1): 647-661
    PubMedGoogle Scholar
  • 3 Kleyn AD. Sudden complete or partial loss of function of the octavus-system in apparently normal persons. Acta Otolaryngol 1944; 32 (5–6): 407-429
    CrossrefGoogle Scholar
  • 4 Chen YS, Emmerling O, Ilgner J, Westhofen M. Idiopathic sudden sensorineural hearing loss in children. Int J Pediatr Otorhinolaryngol 2005; 69 (06) 817-821
    CrossrefPubMedGoogle Scholar
  • 5 Penido NO, Cruz OL, Zanoni A, Inoue DP. Classification and hearing evolution of patients with sudden sensorineural hearing loss. Braz J Med Biol Res 2009; 42 (08) 712-716
    CrossrefPubMedGoogle Scholar
  • 6 Plaza G, Durio E, Herráiz C, Rivera T, García-Berrocal JR. ; Asociación Madrileña de ORL. [Consensus on diagnosis and treatment of sudden hearing loss. Asociación Madrileña de ORL]. Acta Otorrinolaringol Esp 2011; 62 (02) 144-157 (English Edition)
    CrossrefPubMedGoogle Scholar
  • 7 Murphy-Lavoie H, Piper S, Moon RE, Legros T. Hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss. Undersea Hyperb Med 2012; 39 (03) 777-792
    PubMedGoogle Scholar
  • 8 Aslan I, Oysu C, Veyseller B, Baserer N. Does the addition of hyperbaric oxygen therapy to the conventional treatment modalities influence the outcome of sudden deafness?. Otolaryngol Head Neck Surg 2002; 126 (02) 121-126
    CrossrefPubMedGoogle Scholar
  • 9 Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007; 117 (01) 3-15
    CrossrefPubMedGoogle Scholar
  • 10 Soliman S. Speech discrimination audiometry using Arabic phonetically-balanced words. Ain Shams Med J 1976; 27: 27-30
    Google Scholar
  • 11 Shirwany NA, Seidman MD, Tang W. Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol 1998; 19 (02) 230-235
    Google Scholar
  • 12 Şahin M, Göde S, Öztürk K, Bilgen C, Öğüt MF, Kirazlı T. Evaluation of adjuvant intratympanic dexamethasone administration in the treatment of sudden sensorineural hearing loss. J Int Adv Otol 2014; 10 (03) 234-239
    Google Scholar
  • 13 Suzuki H, Fujimura T, Shiomori T. , et al. Prostaglandin E1 versus steroid in combination with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 2008; 35 (02) 192-197
    CrossrefPubMedGoogle Scholar
  • 14 Dallan I, De Vito A, Fattori B. , et al. Intratympanic methylprednisolone in refractory sudden hearing loss: a 27-patient case series with univariate and multivariate analysis. Otol Neurotol 2010; 31 (01) 25-30
    CrossrefPubMedGoogle Scholar
  • 15 Yang J, Huang L, Shi J, Li Y, Wu H, Kong W. [The effect of intratympanic dexamethasone or methylprednisolone on treatment of sudden sensorineural hearing loss]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2010; 24 (13) 594-597
    PubMedGoogle Scholar
  • 16 De Heyn G, Van Opstal M. [Comparative study of acoustic trauma caused by blasts, treated by vasodilators or by a combination of vasodilators and hyperbaric oxygenation]. Acta Otorhinolaryngol Belg 1976; 30 (03) 251-259
    PubMedGoogle Scholar
  • 17 Giger HL. [Therapy of sudden deafness with O2/CO2 inhalation (author's transl)]. HNO 1979; 27 (03) 107-109
    PubMedGoogle Scholar
  • 18 Lamm K, Lamm H, Arnold W. Effect of hyperbaric oxygen therapy in comparison to conventional or placebo therapy or no treatment in idiopathic sudden hearing loss, acoustic trauma, noise-induced hearing loss and tinnitus. A literature survey. Adv Otorhinolaryngol 1998; 54: 86-99
    PubMedGoogle Scholar
  • 19 Gill AL, Bell CN. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM 2004; 97 (07) 385-395
    PubMedGoogle Scholar
  • 20 Bennett MH, Kertesz T, Yeung P. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev 2005; 25 (01) CD004739
    Google Scholar
  • 21 Bennett MH, Kertesz T, Yeung P. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev 2007; 24 (01) CD004739
    Google Scholar
  • 22 Bennett MH, Kertesz T, Perleth M, Yeung P, Lehm JP. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev 2012; 10: CD004739
    PubMedGoogle Scholar
  • 23 Schreiber BE, Agrup C, Haskard DO, Luxon LM. Sudden sensorineural hearing loss. Lancet 2010; 375 (9721): 1203-1211
    CrossrefPubMedGoogle Scholar
  • 24 Agarwal L, Pothier DD. Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2009; 7 (04) CD003422
    Google Scholar
  • 25 Ohno K, Noguchi Y, Kawashima Y, Yagishita K, Kitamura K. Secondary hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss in the subacute and chronic phases. J Med Dent Sci 2010; 57 (02) 127-132
    PubMedGoogle Scholar
  • 26 Nakashima T, Fukuta S, Yanagita N. Hyperbaric oxygen therapy for sudden deafness. Adv Otorhinolaryngol 1998; 54: 100-109
    PubMedGoogle Scholar
  • 27 Desloovere C, Knecht R, Germonpré P. Hyperbaric oxygen therapy after failure of conventional therapy for sudden deafness. B-ENT 2006; 2 (02) 69-73
    PubMedGoogle Scholar
  • 28 Muzzi E, Zennaro B, Visentin R, Soldano F, Sacilotto C. Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: review of rationale and preliminary report. J Laryngol Otol 2010; 124 (02) e2
    CrossrefPubMedGoogle Scholar
  • 29 Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977; 86 (4 Pt 1): 463-480
    CrossrefPubMedGoogle Scholar
  • 30 Stachler RJ, Chandrasekhar SS, Archer SM. , et al; American Academy of Otolaryngology-Head and Neck Surgery. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012; 146 (3, Suppl) S1-S35
    CrossrefPubMedGoogle Scholar